2024-03-28T20:05:52Z
http://repoint.unil.ch/oaiprovider/
oai:serval.unil.ch:BIB_7E8EB5F88A93
2024-03-23T02:35:58Z
openaire
documents
urnserval
serval:BIB_7E8EB5F88A93
EFFICACY OF INTRAVITREAL AFLIBERCEPT IN MACULAR TELANGIECTASIA TYPE 1 IS LINKED TO THE OCULAR ANGIOGENIC PROFILE.
10.1097/IAE.0000000000001424
28002269
000425214400003
Kowalczuk
L.
author
Matet
A.
author
Dirani
A.
author
Daruich
A.
author
Ambresin
A.
author
Mantel
I.
author
Spaide
R.F.
author
Turck
N.
author
Behar-Cohen
F.
author
article
2017-12
2017-12
Retina
1539-2864
0275-004X
journal
37
12
2226-2237
Aged
Angiogenesis Inhibitors/administration & dosage
Bevacizumab/administration & dosage
Dose-Response Relationship, Drug
Drug Resistance
Female
Follow-Up Studies
Humans
Intravitreal Injections
Male
Middle Aged
Receptors, Vascular Endothelial Growth Factor/administration & dosage
Receptors, Vascular Endothelial Growth Factor/antagonists & inhibitors
Recombinant Fusion Proteins/administration & dosage
Retina/pathology
Retinal Telangiectasis/diagnosis
Retinal Telangiectasis/drug therapy
Retrospective Studies
Time Factors
Tomography, Optical Coherence/methods
Treatment Outcome
Visual Acuity
eng
60_published
peer-reviewed
Publication types: Journal Article
Publication Status: ppublish
https://serval.unil.ch/notice/serval:BIB_7E8EB5F88A93
https://serval.unil.ch/resource/serval:BIB_7E8EB5F88A93.P001/REF.pdf
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_7E8EB5F88A932
Copying allowed only for non-profit organizations